Increases in NAD increase lifespan again.... May 6, 2007
Researchers at the Dartmouth University show that a natural product that increases NAD also increases lifespan in yeast. See http://dms.dartmouth.edu/news/2007_h1/print/03may2007_brenner.html
This is no surprise to benaGene users, which have been increasing their NAD levels for some time now....
benaGene Joins the M Prize competition April 15, 2007
Terra Biological has become a competitor in the M-Prize competition to increase the lifespan of mice. See http://www.mprize.org/index.php?pagename=newsdetaildisplay&ID=119
benaGene discussed at Edmonton Aging Conference March 30, 2007
Terra Biological LLC will be presenting a poster at the Edmonton aging conference in Canada on March 30-31, 2007. Additional information can be obtained at www.edmontonagingsymposium.com/
Age Related News Release February 16, 2007
The lifespan of human cells has been increased by up to 70% by increasing the amount of NAD+ in the cells. In a paper by Eric van der Veer and others at the London Health Sciences Centre, genetic engineering was used to increase the enzyme levels of phosphoribosyltransferase (which recycle NAD+ from nicotimamide) and there by increase NAD+ levels.
A copy of the paper can be obtained at http://www.jbc.org/cgi/doi/10.1074/jbc.C700018200
Van der Veer, E. et al, "Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase" 2007 The Journal of Biological Chemistry
Age Related News Release January 3, 2007
Increasing the NAD+ levels after stroke reduces brain cell death in rats by over 70%. NAD+ levels support the activity of the DNA repair enzyme PARP-1, which is used when brain cells are damaged. After a stroke, brain cells quickly deplete NAD+ levels because of upregulation of PARP-1, and the DNA repair rate drops. Addition of external NAD+ greatly reduced the damage from stroke.
More information at: http://www.eurekalert.org/pub_releases/2006-12/uoc--ntp122806.php
News Release December 30, 2006
Interventions Testing Program
Good News, benaGene is currently making it's way through the National Institute on Aging, Interventions Testing Program application process. The news so far is,
"Your proposal to the NIA Interventions Testing Program (ITP) has been reviewed through a two-tier review and prioritization process, and was given a high priority for inclusion in the next round of testing."
NIA/NIH has some additional questions that we have to answer before we will know if benaGene is fully accepted into the program. It looks good so far....
More on the Intervention Testing Program can be found at the following web site: http://www.nia.nih.gov/ResearchInformation/ScientificResources/InterventionsTestingProgram.htm